AstraZeneca established the BioVentureHubin 2014 as an open innovation ecosystem to further strengthen competitiveness and dynamism in the life science industry.The BioVentureHub is based on an innovative public-private-partnership model and is located at the heart of AstraZeneca Gothenburg. It gives emerging life science companies and academic groups a unique opportunity to co-locate with and tap into the power of AstraZeneca’s world-class scientists and state of the art lab facilities and infrastructure, and with each other.
Mission & vision
AstraZeneca set up the AZ BVH to further strengthen the life science ecosystem in Scandinavia. Using resources and capacity in a new way, the hub exposes AstraZeneca to more innovation and science. It stimulates an even more vibrant place to work and generates future collaboration opportunities.
Facts & figures
An innovative way to access life science expertise and infrastructure
of office and laboratory space
Company satisfaction index
Attracting investment and talent
Significant capital raised
between BVH companies
between BVH companies and the life science industry
between BVH companies and AstraZeneca
Catalyzing innovation & knowledge transfer
Sector convergence. Access to innovation programs: AstraZeneca / IBM /Mölnlycke/SMEs / Academia